Gianluca Spitaleri Selected Research

Gianluca Spitaleri Research Topics

Disease

29	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2023 - 03/2004
16	Neoplasms (Cancer) 03/2018 - 05/2004
6	Disease Progression 01/2020 - 05/2007
4	Lung Neoplasms (Lung Cancer) 06/2021 - 04/2011
4	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2006
3	Prostatic Neoplasms (Prostate Cancer) 01/2009 - 05/2007
2	Brain Neoplasms (Brain Tumor) 01/2023 - 01/2016
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2020 - 01/2006
2	Thrombosis (Thrombus) 01/2020 - 01/2006
2	Adenocarcinoma 10/2018 - 09/2013
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2015 - 01/2014
2	Melanoma (Melanoma, Malignant) 01/2014 - 12/2011
2	Pain (Aches) 01/2009 - 09/2007
1	Oncogene Addiction 10/2023
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Pneumonia (Pneumonitis) 06/2021
1	Pulmonary Embolism 01/2020
1	COVID-19 01/2020
1	Anorexia 04/2014
1	Hypophosphatemia 04/2014
1	Asthenia 04/2014
1	Thymoma (Thymic Carcinoma) 01/2014
1	Lymphoma (Lymphomas) 12/2012
1	Mitochondrial Myopathies (Mitochondrial Myopathy) 08/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2010
1	Venous Thromboembolism 10/2005
1	Squamous Cell Carcinoma of Head and Neck 05/2004

Drug/Important Bio-Agent (IBA)

9	Tyrosine Kinase InhibitorsIBA 10/2023 - 11/2011
7	ErbB Receptors (EGF Receptor)IBA 01/2018 - 05/2007
6	Immune Checkpoint InhibitorsIBA 09/2023 - 04/2016
5	CrizotinibIBA 01/2023 - 03/2014
4	Biomarkers (Surrogate Marker)IBA 09/2023 - 09/2007
4	PlatinumIBA 01/2023 - 04/2011
3	Anaplastic Lymphoma KinaseIBA 10/2019 - 06/2015
3	VaccinesIBA 04/2016 - 09/2007
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 02/2015 - 01/2009
3	Interleukin-2 (IL2)IBA 01/2015 - 11/2010
3	Gefitinib (Iressa)FDA Link 01/2009 - 05/2007
3	Hormones (Hormone)IBA 01/2009 - 05/2007
3	Androgen Antagonists (Antiandrogens)IBA 01/2009 - 05/2007
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2009 - 05/2007
2	Gemcitabine FDA Link 03/2018 - 04/2011
2	NivolumabIBA 11/2017 - 01/2016
2	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 01/2014
2	Sorafenib (BAY 43-9006)FDA Link 04/2014 - 01/2014
2	Fibronectins (Fibronectin)IBA 12/2011 - 11/2010
2	Immunoglobulin FragmentsIBA 12/2011 - 11/2010
2	Cisplatin (Platino)FDA LinkGeneric 04/2011 - 05/2004
2	Analgesics (Analgesic Drugs)IBA 01/2009 - 09/2007
2	Fluorouracil (Carac)FDA LinkGeneric 01/2006 - 05/2004
1	Adenosine Monophosphate (AMP)IBA 09/2023
1	Thioredoxin-Disulfide ReductaseIBA 05/2022
1	pembrolizumabIBA 01/2022
1	ensartinibIBA 10/2019
1	5'-Nucleotidase (5' Nucleotidase)IBA 03/2018
1	ceritinibIBA 06/2015
1	EGF Family of ProteinsIBA 02/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	Phosphotransferases (Kinase)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	CytokinesIBA 01/2015
1	Drug CombinationsIBA 01/2015
1	Everolimus FDA Link 04/2014
1	Alanine Transaminase (SGPT)IBA 04/2014
1	Dacarbazine (DIC)FDA LinkGeneric 12/2011
1	asparagine-glycine-arginineIBA 04/2011
1	Pemetrexed (MTA)FDA Link 04/2011
1	Peptides (Polypeptides)IBA 04/2011
1	CD13 Antigens (Alanine Aminopeptidase)IBA 04/2011
1	human CNGRC fusion protein tumor necrosis factor-alphaIBA 04/2011
1	L19-IL2 immunocytokineIBA 11/2010
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2009
1	Cancer VaccinesIBA 09/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2007
1	anilinoquinazolineIBA 05/2007
1	Prothrombin (Factor II)IBA 01/2006
1	factor V LeidenIBA 01/2006
1	Paclitaxel (Taxol)FDA LinkGeneric 05/2004
1	taxaneIBA 05/2004

Therapy/Procedure

8	Therapeutics 09/2023 - 12/2011
7	Drug Therapy (Chemotherapy) 01/2023 - 01/2006
5	Immunotherapy 05/2022 - 09/2007
3	Radiotherapy 01/2020 - 12/2012
3	Catheters 01/2020 - 10/2005
1	Lasers (Laser) 03/2018
1	Combination Drug Therapy (Combination Chemotherapy) 03/2018
1	Liver Transplantation 01/2009
1	Central Venous Catheters 01/2006
1	Intravenous Infusions 05/2004
1	Chemoprevention 03/2004